Telehealth stock Hims & Hers ( HIMS) spiked more than 24% in trading Thursday, days after its Super Bowl ad promoting cheaper GLP-1 weight-loss drugs sparked controversy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback